Durect (DRRX)

[realfast95]

milestones
Q3 complete dosing patients in PERSIST in the third quarter. PERSIST, a Phase 3
Q4 PERSIST, a Phase 3, top-line results

for now it's a bio-tech and overall market watch.

BREAKOUT WATCH for possible breakout above 1.61, no resistance in area just above.
Type: Continuation breakout from single resistance.
Target: 1.8, 12.5% Stop: 1.53 Loss: 4.4% P/L ratio: 2.8 : 1 - Good
BREAKDOWN WATCH for possible breakdown below 1.52, no support in area just below.
Type: Continuation breakdown from single support.
Target: 1.33, 16.9% Cover: 1.66 Loss: 3.7% P/L ratio: 4.6 : 1 - Excellent

-------------------------------------------------
TARGET 1 Price: 1.65 Profit: 3.1% (Typical rally)
Stop/Trailing Stop: 1.53 Loss: 4.4%
P/L Ratio: 0.7 : 1 - Poor
POTENTIAL Excellent, there are 1 resistance areas on the way to Target 1.
Stocks may quickly rise to Targets when there are few resistance areas
TARGET 1 RESISTANCE Current price at resistance: 1.57 ± 0.04 type single, strength 3
+3.1% at 1.65 is Target 1
TARGET 2 Price: 1.72 Profit: 7.5% P/L Ratio: 1.7 : 1 - Poor (Extreme rally)